CLSI M64
Implementation of Taxonomy Nomenclature Changes, 1st Edition
This CLSI guideline provides recommendations for implementing nomenclature changes in bacteria and fungi identified from clinical specimens. It ensures accurate reporting in antimicrobial susceptibility testing and diagnostic microbiology. The guideline helps laboratories adapt to updated taxonomic classifications while maintaining clarity in clinical communications.
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceClinical and Laboratory Standards Institute M64—Implementation of Taxonomy Nomenclature Changes provides background and historic information related to the process of microbial taxon discovery, publication, and acceptance by recognized professional committees and societies. Additional nuances within these topics exist in the field of medical mycology. CLSI M64 reflects collaborative discussions from experts in the fields of medical bacteriology, medical mycology, veterinary diagnostic microbiology, antimicrobial susceptibility testing, and diagnostics manufacturing. Recommendations are provided for the implementation of novel and revised taxonomy in human and veterinary microbiology laboratories. A two- to three-year timeline is presented for laboratories to enact these changes; changes that may more profoundly affect patient care can be acted upon more expediently. Communication with clinical and public health stakeholders is imperative to the successful implementation of taxonomic changes.
CLSI M64 focuses on nomenclature changes for medically important bacteria and fungi that are included in CLSI documents, especially CLSI antimicrobial susceptibility testing (AST) standards and guidelines, as well as documents that cover molecular techniques that apply to bacteria and fungi. Veterinary pathogens are also included. CLSI M64 is intended for use by human and veterinary microbiology laboratory personnel, as well as primary and consulting care clinicians, pharmacists, and infection preventionists. CLSI M64 discusses how and why changes to the nomenclature are made. It includes guidelines for assessing the effect of a nomenclature change on clinical care (eg, factors to consider). It includes tables with examples of changes proposed in the literature, a brief summary of why the changes are proposed, recommendations for reporting in a medical laboratory, and statements on the clinical effects of the recommendations. CLSI M64 does not include nomenclature changes for parasites and viruses causing disease in humans and animals.
Clinical and Laboratory Standards Institute M64—Implementation of Taxonomy Nomenclature Changes provides background and historic information related to the process of microbial taxon discovery, publication, and acceptance by recognized professional committees and societies. Additional nuances within these topics exist in the field of medical mycology. CLSI M64 reflects collaborative discussions from experts in the fields of medical bacteriology, medical mycology, veterinary diagnostic microbiology, antimicrobial susceptibility testing, and diagnostics manufacturing. Recommendations are provided for the implementation of novel and revised taxonomy in human and veterinary microbiology laboratories. A two- to three-year timeline is presented for laboratories to enact these changes; changes that may more profoundly affect patient care can be acted upon more expediently. Communication with clinical and public health stakeholders is imperative to the successful implementation of taxonomic changes.
CLSI M64 focuses on nomenclature changes for medically important bacteria and fungi that are included in CLSI documents, especially CLSI antimicrobial susceptibility testing (AST) standards and guidelines, as well as documents that cover molecular techniques that apply to bacteria and fungi. Veterinary pathogens are also included. CLSI M64 is intended for use by human and veterinary microbiology laboratory personnel, as well as primary and consulting care clinicians, pharmacists, and infection preventionists. CLSI M64 discusses how and why changes to the nomenclature are made. It includes guidelines for assessing the effect of a nomenclature change on clinical care (eg, factors to consider). It includes tables with examples of changes proposed in the literature, a brief summary of why the changes are proposed, recommendations for reporting in a medical laboratory, and statements on the clinical effects of the recommendations. CLSI M64 does not include nomenclature changes for parasites and viruses causing disease in humans and animals.